You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Citation Tools

Article menu

Download PDFPDF

Poster Presentation
Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
de Gruijl TD, Koster BD, van den Hout MF, et al
Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
Journal for ImmunoTherapy of Cancer 2015;3:P201. doi: 10.1186/2051-1426-3-S2-P201